Drug information provided by: Merative, Micromedex®
Lucinactant injection is used to prevent respiratory distress syndrome (RDS) in premature infants at risk for RDS. RDS is a breathing or lung problem which is more common in premature infants because their lungs are not making enough surfactant. Surfactant is a liquid produced naturally in the lungs that helps an infant breathe air normally.
This medicine is to be given only by or under the direct supervision of a doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now and help create new and better solutions for more than 1.3 million patients who turn to Mayo Clinic each year.